Patents by Inventor Robert Joseph ABRAHAM

Robert Joseph ABRAHAM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230285659
    Abstract: A delivery device for intravenous delivery of microparticles to a patient. The delivery device is fluidly connectable to (i) a first source of an injection medium and (ii) a second source of an injection medium. The delivery device includes: a first fluid inlet fluidly connectable to the first source of the injection medium, a fluid outlet, a fluid mixer fluidly connecting the first fluid inlet to the fluid outlet, a second fluid inlet fluidly connectable to the second source of the injection medium, and a source of microparticles fluidly connecting the second fluid inlet to the fluid mixer. When fluid flows from the second source of the injection medium into the delivery device: the second injection medium fluidly drives microparticles from the source of microparticles into the fluid mixer, and the fluid outlet dispenses to the patient an injection medium that includes the microparticles.
    Type: Application
    Filed: October 19, 2022
    Publication date: September 14, 2023
    Inventors: David Mark Douglas HODGSON, Marc Andre GREGOIRE, Kathryn Margaret Ann ATWELL, Gary Michael DONOFRIO, Robert Joseph ABRAHAM, Evan Christopher WIENS, Brenna Catherine KETTLEWELL
  • Patent number: 11504468
    Abstract: A delivery device for intravenous delivery of microparticles to a patient. The delivery device is fluidly connectable to (i) a first source of an injection medium and (ii) a second source of an injection medium. The delivery device includes: a first fluid inlet fluidly connectable to the first source of the injection medium, a fluid outlet, a fluid mixer fluidly connecting the first fluid inlet to the fluid outlet, a second fluid inlet fluidly connectable to the second source of the injection medium, and a source of microparticles fluidly connecting the second fluid inlet to the fluid mixer. When fluid flows from the second source of the injection medium into the delivery device: the second injection medium fluidly drives microparticles from the source of microparticles into the fluid mixer, and the fluid outlet dispenses to the patient an injection medium that includes the microparticles.
    Type: Grant
    Filed: October 18, 2019
    Date of Patent: November 22, 2022
    Assignee: ABK Biomedical Incorporated
    Inventors: David Mark Douglas Hodgson, Marc Andre Gregoire, Kathryn Margaret Ann Atwell, Gary Michael Donofrio, Robert Joseph Abraham, Evan Christopher Wiens, Brenna Catherine Kettlewell
  • Publication number: 20210369947
    Abstract: A delivery device for intravenous delivery of microparticles to a patient. The delivery device is fluidly connectable to (i) a first source of an injection medium and (ii) a second source of an injection medium. The delivery device includes: a first fluid inlet fluidly connectable to the first source of the injection medium, a fluid outlet, a fluid mixer fluidly connecting the first fluid inlet to the fluid outlet, a second fluid inlet fluidly connectable to the second source of the injection medium, and a source of microparticles fluidly connecting the second fluid inlet to the fluid mixer. When fluid flows from the second source of the injection medium into the delivery device: the second injection medium fluidly drives microparticles from the source of microparticles into the fluid mixer, and the fluid outlet dispenses to the patient an injection medium that includes the microparticles.
    Type: Application
    Filed: October 18, 2019
    Publication date: December 2, 2021
    Inventors: David Mark Douglas HODGSON, Marc Andre GREGOIRE, Kathryn Margaret Ann ATWELL, Gary Michael DONOFRIO, Robert Joseph ABRAHAM, Evan Christopher WIENS, Brenna Catherine KETTLEWELL
  • Patent number: 11083806
    Abstract: Provided are radiopaque compositions comprising one or more of yttrium (Y), strontium (Sr), gallium (Ga), and silicon, or oxides and salts thereof. The composition can comprise a combination of Y2O3, SrO, Ga2O3, and SiO2, and optionally MnO2, and TiO2. Other compositions comprise SrO, Ga2O3, TiO2, MnO2, and SiO2. The composition can be a particulate material. The compositions are useful for radioembolization to treat tumors.
    Type: Grant
    Filed: November 26, 2015
    Date of Patent: August 10, 2021
    Assignee: ABK Biomedical Incorporated
    Inventors: Daniel Boyd, Robert Joseph Abraham, Xiaofang Zhang, Sharon Legere, James Clarke
  • Publication number: 20170360968
    Abstract: Provided are radiopaque compositions comprising one or more of yttrium (Y), strontium (Sr), gallium (Ga), and silicon, or oxides and salts thereof. The composition can comprise a combination of Y2O3, SrCO3, Ga2O3, and SiO2, and optionally MnO2, and TiO2. Other compositions comprise SrCO3, Ga2O3, TiO2, MnO2, and SiO2. The composition can be a particulate material. The compositions are useful for radioembolization to treat tumors.
    Type: Application
    Filed: November 26, 2015
    Publication date: December 21, 2017
    Inventors: Daniel BOYD, Robert Joseph ABRAHAM, Xiaofang ZHANG, Sharon KEHOE, James CLARKE